Levetiracetam administration for the management of levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled, crossover trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Therapeutic Use
- Acronyms VALID-PD
- 14 Nov 2007 Status changed from recruiting to in progress.
- 12 Nov 2006 New trial record.